Thomas Lemmin

University of California, San Francisco

Papers

1

Total Citations

37

H-Index

1

About

Dr. Thomas Lemmin is a leading computational biologist whose research lies at the intersection of bioinformatics, structural biology, and immunology, with a primary focus on understanding B-cell immunity and antibody responses. His most notable contribution is the development of "antibodyomics"—a suite of bioinformatics technologies designed to decode the complex immune response to HIV-1. In his highly cited 2017 work, Dr. Lemmin addressed the critical challenge of how to elicit broadly neutralizing antibodies (bnAbs) through vaccination, providing a framework for analyzing the vast repertoire of antibodies generated during HIV-1 infection. By integrating structural and sequence data, his research has illuminated the pathways by which the immune system can target conserved viral epitopes. With over 37 citations on this seminal paper alone, his work has had a significant impact on the field, guiding experimental efforts toward rational vaccine design. Dr. Lemmin’s contributions are essential for any researcher seeking to bridge the gap between computational predictions and the development of effective immunotherapies against rapidly mutating pathogens.

Research Focus

Key Achievements

1
H-Index
1
Papers
37
Total Citations
37
Avg Citations/Paper
🏆 Most Cited Paper
Antibodyomics: bioinformatics technologies for understanding B‐cell immunity to <scp>HIV</scp>‐1
37 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University of California, San Francisco

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago